Clinical Trial

Multi-center Clinical Study on Hemoperfusion of KHA80

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 14, 2025 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the decreasing rate of blood IL-6, β2-MG and PTH in maintenance hemodialysis patients in the 52nd week compared with routine hemodialysis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-22.
Status change: Not Yet Recruiting → Recruiting 2025-01-10
Trial Details
NCT Number NCT06233838
Lead Sponsor First Affiliated Hospital of Fujian Medical University
Conditions Uremia, Uremic Osteodystrophy, Dialysis Related Complication
Enrollment 394 participants
Start Date 2025-01-13
Primary Completion 2026-02-28 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-14